This description is the more technical of two documents. The other document is called A TREATMENT FOR AIDS. Please read that document first.
AIDS is a social issue. Throughout the world it affects millions of individuals in a variety of living conditions and in societies of varying incomes and resources. A successful treatment for the disease must be available to these persons in an effective form. The goal of this article is to outline how clinical treatment can be accomplished world wide in a period of less than two years from today
The creation of a treatment program consists of determining the configuration of a single machine to combat the disease, to duplicate the machine in the thousands, to distribute the devices in a clinical environment, and to make the individuals aware of their availability. The machine is a simple design. It extracts blood from the client at a continuous rate, creates a set of interference grids through which the blood passes, and returns the blood to the client, cleansed of adult HIV. Extracting blood and transporting it through the process is not a difficult task. Our current application of clinical kidney dialysis has already solved much of the mechanics. Since the advent of diagnosed AIDS, the process that prevents viral contamination between clients has also been resolved. The basis of my clinical approach is the adaptation of techniques used in clinical dialysis.
What must be developed is the actual mechanics of presenting the blood to the interference grids, and to develop these grids into effective mechanisms. Separating the actual blood from the machine’s active elements appears to be the standard form of minimizing cross-contamination between clients. The physical conductor of the blood through the device would appear to best be in a disposable form, or in a form that is individual to the client. The clinical process of preparing the equipment for the next client would involve the removal from the machine of the conductor, and its replacement that is unique for this treatment session (disposable), or is the conductor assigned to the individual client. These alternatives will be determined by the economics of the clinical environment. The conductor would consist of what is essentially a tube that is responsible for accepting the blood from the extraction catheter, transporting it through a pumping apparatus, carrying the blood through the interference grid section, and discharging the blood into a return catheter to complete the circuit. It must be flexible to permit the pumping section to function through its walls, and in the grid section, it must provide the maximum transmission of the patterns into the blood.
The conductor, then is to be a blow-molded plastic vessel that may contain some very specific geometry, and in some sections would have a very specific thin-walled profile (grid section). By using blow-molded conductors ensures the minimum cost-per-client for the clinical process. These conductors may prove to be a difficult thing to mass produce using blow-molding techniques, but the technology available to the industry indicates there to be no barrier here to the development of the clinical system. To understand the grid section that actively destroys the virus cells requires a grasp of the physics and the medium. The physics again is simple in concept. A set of light beams is emitted by individual lasers. The beams travel from the lasers through the membrane wall of the plastic conductor, and through the blood. These lasers are positioned in sets to permit each set’s beams to intersect while passing through the blood. The region in the blood where a set of beams intersects is an individual grid, and each grid slices a cross section of the blood as it travels inside the grid section. The optimal condition for these grids is for each grid to occupy an entire cross section of the conductor, allowing no blood to pass through the conductor that does not travel within each individual grid. Thus all the blood will pass through each grid. The grids are to be lined up along the conduit’s path in the grid section.
Each beam is created by one laser. Lasers are to be used for their stability of emitted frequency. This stability must be maintained to a high level of confidence, and my opinion is that the temperature of the lasers will require some form of external regulation. Thus, a water bath or some more elegant means of temperature control for the lasers of the grid section will be included in the clinical machine.
As the beams converge within the blood, their discrete frequencies dissolve into each other in a manner described by a very specific mathematical model of interferometry, which is a large word, but a well-understood physics principle. Lasers themselves could not be designed without this understanding. Diode lasers or some similar forms of solid-state lasers are indicated. Here again, every compact disk player has a diode laser that reads the disk. The technology is well known and easily applied to the clinical application. The mathematical model is the key, and actually the only real research required to institute this program.
The model then consists of a generated field in space (the grid section) in which the beams converge and blend, with the result being a region filled with energy that cavitates matter in three dimensions. Roughly, the waves of the converging beams act upon each other to create pockets that are sized to mimic the volume of individual adult HIV virus shells (virophage). The energy of the beams is discharged into all of the physical components of blood as each travels through the grid. In a properly configured grid, the form of energy presented to the blood’s components is easily absorbed by the human components, but the viral material sustains sympathetic vibration related directly to size, and are fractured or pulverized. By supplying sufficient energy, the assurance of total destruction of the included virus cells is possible, returning only dead adult virus to the body as the client’s blood is returned.
Blood contains many components that react to the beams by absorbing them, reducing effectiveness. Each of the major blood components requires a set of beams and a discrete grid. Their combined obstruction to the process is eliminated. Red corpuscles absorb one band of light and transmit others. By tailoring one grid to accommodate the red cells, their obstruction is eliminated. Another grid is tuned to the best frequency family to ignore the white blood cells. This selection of grid frequencies can become as detailed as needed to prove clinically effective. By encompassing the scope of blood components and including individual grids in the grid section for each, the clinical device can ensure that the exposure of no viral cells is occluded by adjacent human structures. Since there is very little resemblance between the physical size and shape of viral cells and those of human blood, there is a very great expanse between the threshold of this type of energy required to destroy the viral cells and the minimum energy required to injure human blood cells. It means that once the proper frequency sets and patterns are mathematically developed, constructed and applied, there is very little risk of damaging the blood. The amplitude and intensity that may be applied, range to the level of brutal to the viral cells, yet the blood will be unaffected.
The choice of frequencies is a matter of physics. Interferometry is based upon the blending of two or more separate frequencies. To create the energy boxes of so small size requires that the set of frequencies for each grid be of emissions of a very small frequency separation for each grid. The band for each grid’s emissions is very broad. It means that the frequency selection is almost open. Light frequencies are indicated since they do not harm human cells and are shown to destroy virus cells. Within that band, the choice is unlimited. Harsh x-rays or hard ultra violet frequencies need not be used.
Cost of these grids is almost negligible in mass production, easily less than one or two thousand American dollars per grid section. The financial issue is based upon the determined requirements for the electrical and thermal conditions of the components. This may prove to be sizable, as stability in this process is paramount, especially when combined with the prerequisite necessity to perform in adverse and varietal international conditions. To be clear, the electrical and thermal requirements are not in need of new technology, they are just expensive. Another advantage to this clinical process is that it can cheaply, rapidly and easily be reconfigured to be effective against any virus form, once the virus cell’s physical configuration is known. It can be adapted to mutations, though I believe that the original device will prove effective for all forms of HIV at once. This feature permits the shipment of these machines to the crisis center of any new virus outbreak, where they can be configured in the field with minor software or hardware refit, and be effective in a time span of less than a week. One machine could see application toward a dozen virus species in a decade, and should be designed to do so. Philosophically, since the technology can combat viral leukemia and Ebola as readily as HIV, its funding and distribution are more acceptable in some social structures, and are universally justifiable.
The application of this clinical approach to virus-based crises is only a treatment, not a cure.
Also, its process does not interfere with those measures of control through pharmaceuticals, and gives the client more opportunity to cultivate antibodies naturally. It may provide an individual with sufficient time to develop a clone-able antibody that would constitute a cure. When these grids increase in size to insert an entire human, then this clinical treatment becomes a cure.
The pressure to enlarge the grid size will be driven by the industrial application of the technology. Since blood is a complex fluid, the conversion of clinical equipment to eliminate viruses from industrial fluids is simple, while keeping them chemically pure. The pharmaceutical industry requirements alone will drive development. Eventually, grids a meter across will control virus flow through both drains and water sources, improving the human condition.
Development of this technology also does not interfere with the research being continued for biological treatment. The individuals involved and the equipment resources are different. This development program will use laser technology and electronics in separate laboratories. This treatment program will be independent of pharmaceutical programs, so no currently active resources will be compromised.
There is a threat in our world for combatants to resort to viral warfare. Since the form of virus cannot be determined until the event, there are few means currently available for military medical staff to respond. This technology has the capability to treat the soldier in field hospital conditions, or in severe quarantine. The technology is configured to be portable, and can be useful in treatment within days of contamination. An armed service can for the first time expect that its soldiers in the field can be saved from this form of assault.